AstraZeneca
The role provides scientific leadership for AI‑powered computational pathology and multimodal biomarker development within AstraZeneca's Oncology and BioPharma portfolio. The leader will partner with cross‑functional teams to design and execute biomarker strategies, integrate diverse data modalities, and drive translational insights that support patient selection and drug development.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
4% below the average for this role
Principal Scientist, Translational Computational Biology
Bristol Myers Squibb
Postdoctoral Research Fellow, Computational Pathology and Spatial AI
Merck & Co., Inc.
Computational Scientist – Biomarker Development (m/f/d)
tubulis
Director, Computational Biology
Takeda Pharmaceutical Company Limited
Computational Biology Postdoctoral Fellow
Memorial Sloan Kettering Cancer Center
Director, Emerging Diagnostic Technologies
GSK plc